The immunogenicity of therapeutic factor VIII (FVIII) in patients with haemophilia A remains a critical issue in patient management. This review describes the immunological processes involved in the activation of the immune system against FVIII, with a particular focus on the role of endocytic receptors for the recognition of FVIII by antigen-presenting cells.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1160/TH10-05-0294 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!